A list of the top diabetes stocks includes Abbott Laboratories, known for its advanced continuous glucose monitoring technology. Despite recent legal issues, analysts maintain a positive outlook with a 14.11% upside potential, emphasizing Abbott's position as a leader in diabetes care solutions.